Home > PB Ratio > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES
PB (Price/Book ) Ratio

The Current P/B Ratio of SUDARSHAN PHARMA INDUSTRIES is 6.53.

Share Price ₹39.8Aug 24,2026
Market Cap ₹1,012.9 Cr
Book Value₹155.1 CrMar2026 - Consolidated Results
Price/Book 6.53xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results

Definition & Calculation of PB (Price/Book ) ratio of SUDARSHAN PHARMA INDUSTRIES

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of SUDARSHAN PHARMA INDUSTRIES is calculated as :

Current Market Cap [ ₹1,012.9 Cr] as on Aug 24,2026

(/) Book Value [ ₹155.1 Cr] based on Mar2026 - Consolidated Results

(=) P/B Ratio [ 6.53x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for SUDARSHAN PHARMA INDUSTRIES , the investors are currently willing to pay '6.53 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SUDARSHAN PHARMA INDUSTRIES !

The chart below summarizes the trend in P/B Ratio of SUDARSHAN PHARMA INDUSTRIES over the last five years.

Historical PB (Price/Book ) ratio chart of SUDARSHAN PHARMA INDUSTRIES


PB Ratio Performance Analysis for SUDARSHAN PHARMA INDUSTRIES

- SUDARSHAN PHARMA INDUSTRIES 's latest p/b ratio is 6.53x.

- SUDARSHAN PHARMA INDUSTRIES 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.74x.

- SUDARSHAN PHARMA INDUSTRIES 's operated at median p/b ratio of 1.33x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUDARSHAN PHARMA INDUSTRIES 's p/b ratio peaked in Mar2025 at 5.76x.

- SUDARSHAN PHARMA INDUSTRIES 's p/b ratio hit its five-year low in Mar2022 of 0x.


How does SUDARSHAN PHARMA INDUSTRIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
SUDARSHAN PHARMA INDUSTRIES 155.106.531,012.9
SUN PHARMACEUTICAL INDUSTRIES LTD83,570.105.48458,249.0
DIVIS LABORATORIES LTD16,761.0013.46225,648.0
TORRENT PHARMACEUTICALS LTD8,388.4322.04184,891.0
CIPLA LTD34,369.403.37115,927.0
DR REDDYS LABORATORIES LTD37,742.602.6499,702.0
MANKIND PHARMA LTD16,252.606.0498,086.5
LUPIN LTD22,384.104.47100,134.0
ZYDUS LIFESCIENCES LTD27,111.404.05109,825.0
AUROBINDO PHARMA LTD37,891.002.4492,612.8
LAURUS LABS LTD5,275.0818.4097,053.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SUDARSHAN PHARMA INDUSTRIES 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.44x
Max industry PB 22.04x
Median industry PB 5.48x
Average industry PB 8.08x



You may also like the below Video Courses